Peptide Analogs

Tirzepatide

Also catalogued as: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20-diacid-linker)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Synthetic 39-residue peptide with aminoisobutyric-acid residues and a C20 fatty-diacid conjugate at Lys20.

Size

Purity 99.69% — lowest of 3 laboratories · lot EP-A1039 · 30mg certificates →

3 passing reports on record · Batch target: 3

For in-vitro laboratory research by qualified professionals. Not for human or veterinary use.

Specifications

INN: Tirzepatide
IUPAC / systematic name: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20-diacid-linker)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Chemical class: Acylated Peptide Analog
CAS registry: 2023788-19-2 · PubChem
Molecular weight: 4,813.5 g/mol
Amino acids: 39
Form: Lyophilized powder
Structure note: C20 fatty-diacid chain at Lys20; C-terminal amide

Quality documentation

Passing reports on record for each compound-size lot, counted once per laboratory. Purity is the lowest reported passing figure. Each batch has its own testing target; meeting it is one requirement for release.

30mg: lot EP-A1039 · purity 99.69% · 3 passing reports on record · Batch target: 3
60mg: lot EP-B1040 · purity 99.42% · 3 passing reports on record · Batch target: 3

Intended use

For in-vitro laboratory research by qualified professionals. Not for human or veterinary use of any kind — not a drug, food, cosmetic or supplement. The buyer is responsible for lawful handling, storage and disposal.

Researchers should consult the primary scientific literature for published experimental protocols and conditions relevant to their specific in-vitro or laboratory applications.

Certificates of analysis

Per size, per lot — the testing record.

30mg · lot EP-A1039

3 passing reports on record · Batch target: 3

Aegis Analytical

Purity 99.69%

Lot EP-A1039 · tested 2026-02-04